
    
      The purpose of this trial is to assess, by product, safety and performance post-market of the
      Microraptor Regenesorb, Microraptor Knotless Regenesorb, and Microraptor Knotless PEEK Suture
      Anchors. Approximately 18 sites (approximately 3 sites for study shoulder group and 3 sites
      for study hip group, per product) in the United States will participate in the study. This is
      an open-label study with consecutive enrollment. The study will continue for 24 months from
      the date that the last subject received the study treatment to the date that the last subject
      completes the study as planned. The study duration is planned for 36 months.
    
  